Team
Matthew specialises in patent litigation, opinion work, supplementary protection certificates (SPCs), paediatric extensions and regulatory advice.
Matthew has a strong science background, holding a PhD in molecular immunology, meaning he gets to grips with the scientific facts of a case quickly.
A leading individual in Chambers and is a rising star in litigation, Matthew has particular experience of acting for clients in the pharmaeutical, biotech and life sciences sectors. He regularly co-ordinates pan-European litigation and has been involved in hearings in Germany, Netherlands, Belgium and Norway.
Since 2015 | Partner, Taylor Wessing |
2011 - 2015 | Senior Associate, Taylor Wessing |
2006 - 2011 | Associate, Taylor Wessing |
2004 - 2006 | Trainee solicitor, Taylor Wessing |
2007 | Diploma in Intellectual Property Law, Bristol University, UK |
2006 | Admitted to the Bar, England and Wales |
2002 | PhD, Molecular Immunology, University of Cambridge, UK |
1998 | Degree, Medical Microbiology, University of Edinburgh, UK |
EU Guidance on biosimilar MAbs - what took so long?, Scrip Regulatory Affairs, pp 10-12, 17, July 2012 |
Associate member of CIPA |
English |
Aktuelle News & Insights
This year's trainee retention and salary increases
von mehreren Autoren
Biologics and biosimilars litigation update
von Matthew Royle, Ph.D. und Dr. Nora E. Wessendorf, LL.M. (Washington)
Biologics and biosimilars litigation update
Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents
von mehreren Autoren